Platelet-derived TGF-β and platelet-tumor cell interaction activate the TGF-β and nuclear factor kappa light chain enhancer of activated B cells (NF-κB) pathways in cancer cells, resulting in EMT phenotype and enhanced metastasis in vivo. The gene discussed is NFKB1; the disease is cancer.